Similar articles for PMID: 25075007

Year	Number of Results
1912	1
1994	1
1999	1
2001	3
2002	6
2003	8
2004	3
2005	5
2006	7
2007	12
2008	11
2009	7
2010	16
2011	7
2012	9
2013	6
2014	13
2015	10
2016	10
2017	6
2018	4
2019	4
2020	6
2021	7
2022	3
2024	0

1

The RECK gene and biological malignancy--its significance in angiogenesis and inhibition of matrix metalloproteinases.

Alexius-Lindgren M, Andersson E, Lindstedt I, Engström W. Alexius-Lindgren M, et al. Anticancer Res. 2014 Aug;34(8):3867-73. Anticancer Res. 2014. PMID: 25075007 Review.

2

RECK, a novel matrix metalloproteinase regulator.

Meng N, Li Y, Zhang H, Sun XF. Meng N, et al. Histol Histopathol. 2008 Aug;23(8):1003-10. doi: 10.14670/HH-23.1003. Histol Histopathol. 2008. PMID: 18498076 Review.

3

Potential Role of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Regulation of Matrix Metalloproteinases (MMPs) Expression in Periodontal Diseases.

Liu N, Zhou B, Zhu G. Liu N, et al. Med Sci Monit. 2016 Jun 7;22:1936-8. doi: 10.12659/msm.896546. Med Sci Monit. 2016. PMID: 27272560 Free PMC article.

4

Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2.

Jacomasso T, Trombetta-Lima M, Sogayar MC, Winnischofer SM. Jacomasso T, et al. Melanoma Res. 2014 Feb;24(1):32-9. doi: 10.1097/CMR.0000000000000039. Melanoma Res. 2014. PMID: 24335752

5

The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis.

Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, Ide C, Horan TP, Arakawa T, Yoshida H, Nishikawa S, Itoh Y, Seiki M, Itohara S, Takahashi C, Noda M. Oh J, et al. Cell. 2001 Dec 14;107(6):789-800. doi: 10.1016/s0092-8674(01)00597-9. Cell. 2001. PMID: 11747814 Free article.

6

A Hypothesis for the Role of RECK in Angiogenesis.

Gutiérrez J, Droppelmann CA, Salsoso R, Westermeier F, Toledo F, Salomon C, Sanhueza C, Pardo F, Leiva A, Sobrevia L. Gutiérrez J, et al. Curr Vasc Pharmacol. 2016;14(1):106-15. doi: 10.2174/1570161113666151014130746. Curr Vasc Pharmacol. 2016. PMID: 26463982 Review.

7

Expression of matrix metalloproteinases-2, -9 and reversion-inducing cysteine-rich protein with Kazal motifs in gingiva in periodontal health and disease.

Liu N, Cao Y, Zhu G. Liu N, et al. Arch Oral Biol. 2017 Mar;75:62-67. doi: 10.1016/j.archoralbio.2016.12.009. Epub 2016 Dec 26. Arch Oral Biol. 2017. PMID: 28043014

8

Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.

Span PN, Sweep CG, Manders P, Beex LV, Leppert D, Lindberg RL. Span PN, et al. Cancer. 2003 Jun 1;97(11):2710-5. doi: 10.1002/cncr.11395. Cancer. 2003. PMID: 12767082 Free article.

9

RECKing MMP: relevance of reversion-inducing cysteine-rich protein with kazal motifs as a prognostic marker and therapeutic target for cancer (a review).

Nagini S. Nagini S. Anticancer Agents Med Chem. 2012 Sep;12(7):718-25. doi: 10.2174/187152012802650237. Anticancer Agents Med Chem. 2012. PMID: 22292753 Review.

10

RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer.

Clark JC, Thomas DM, Choong PF, Dass CR. Clark JC, et al. Cancer Metastasis Rev. 2007 Dec;26(3-4):675-83. doi: 10.1007/s10555-007-9093-8. Cancer Metastasis Rev. 2007. PMID: 17828469 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

147 results

Results by year